Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Amyloidosis × GTP Cyclohydrolase × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Amyloidosis 1

Interventions

Dexamethasone 5 Lenalidomide 2 Cyclophosphamide 2 Calcium Dobesilate 2 ixazomib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carfilzomib 1 belantamab mafodotin 1 auricularum 1 Thalidomide 1 Melphalan 1 Lisaftoclax 1 GTP Cyclohydrolase 1 Drug Evaluation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04942067 2023-10-25

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma

Ascentage Pharma Group Inc.

Phase 1/2 Unknown

Amyloidosis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡